Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer
Open Access
- 30 September 2011
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 73 (3), 289-293
- https://doi.org/10.1016/j.lungcan.2011.01.003
Abstract
No abstract availableFunding Information
- NIH
- Avon Foundation
- Lynn Sage Foundation
- Northwestern Memorial Foundation and Friends of Prentice
This publication has 27 references indexed in Scilit:
- High Aromatase Expression in Uterine Leiomyoma Tissues of African-American WomenJournal of Clinical Endocrinology & Metabolism, 2009
- Targeting Aromatase and Estrogen Signaling in Human Non‐Small Cell Lung CancerAnnals of the New York Academy of Sciences, 2009
- Expression of aromatase CYP19 and its relationship with parameters in NSCLCFrontiers in Bioscience-Landmark, 2009
- Novel Promoter I.8 and Promoter Usage in the CYP19 (Aromatase) GeneReproductive Sciences, 2008
- Aromatase Inhibitors in Human Lung Cancer TherapyCancer Research, 2005
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cellsSteroids, 2005
- Combined Targeting of the Estrogen Receptor and the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Shows Enhanced Antiproliferative EffectsCancer Research, 2005
- Overexpression of Aromatase P450 in Leiomyoma Tissue Is Driven Primarily through Promoter I.4 of the Aromatase P450 Gene (CYP19)Journal of Clinical Endocrinology & Metabolism, 2002
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) geneEndocrinology, 1996